Lipocine Stock Buy Hold or Sell Recommendation
| LPCN Stock | USD 4.80 0.27 5.33% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Lipocine is 'Hold'. Macroaxis provides Lipocine buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Lipocine positions. The advice algorithm takes into account all of Lipocine's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Lipocine's buy or sell advice are summarized below:
Real Value 12.66 | Target Price 36.33 | Hype Value 4.7 | Market Value 4.8 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Lipocine given historical horizon and risk tolerance towards Lipocine. When Macroaxis issues a 'buy' or 'sell' recommendation for Lipocine, the advice is generated through an automated system that utilizes algorithms and statistical models.
Lipocine |
Execute Lipocine Buy or Sell Advice
The Lipocine recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lipocine. Macroaxis does not own or have any residual interests in Lipocine or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lipocine's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Lipocine Trading Alerts and Improvement Suggestions
| Lipocine is way too risky over 90 days horizon | |
| Lipocine appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 109.99 K. Net Loss for the year was (16.35 M) with profit before overhead, payroll, taxes, and interest of 500 K. | |
| Lipocine currently holds about 37.4 M in cash with (11.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42. | |
| Lipocine has a poor financial position based on the latest SEC disclosures | |
| Latest headline from investing.com: Lipocine reports positive results from obesity treatment trial |
Lipocine Returns Distribution Density
The distribution of Lipocine's historical returns is an attempt to chart the uncertainty of Lipocine's future price movements. The chart of the probability distribution of Lipocine daily returns describes the distribution of returns around its average expected value. We use Lipocine price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lipocine returns is essential to provide solid investment advice for Lipocine.
| Mean Return | 0.50 | Value At Risk | -6.49 | Potential Upside | 11.76 | Standard Deviation | 5.43 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lipocine historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lipocine Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Lipocine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lipocine backward and forwards among themselves. Lipocine's institutional investor refers to the entity that pools money to purchase Lipocine's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Royal Bank Of Canada | 2023-12-31 | 91.0 | Fmr Inc | 2023-12-31 | 90.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 68.0 | Tidemark Llc | 2023-12-31 | 59.0 | Group One Trading, Lp | 2023-12-31 | 52.0 | Wells Fargo & Co | 2023-12-31 | 41.0 | Jpmorgan Chase & Co | 2023-12-31 | 9.0 | Bank Of America Corp | 2023-12-31 | 6.0 | Bridgeway Capital Management, Llc | 2023-09-30 | 0.0 | Vanguard Group Inc | 2023-12-31 | 221.5 K | Blackrock Inc | 2023-12-31 | 74.8 K |
Lipocine Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.7M | 9.5M | (21.3M) | 197.9K | 1.6M | 1.7M | |
| Free Cash Flow | (11.7M) | (15.3M) | (4.4M) | (12.1M) | (11.9M) | (12.5M) | |
| Other Non Cash Items | 221.2K | 109.3K | 53.8K | (932.1K) | 973.5K | 1.0M | |
| Net Income | (13.0M) | (21.0M) | (634.4K) | (10.8M) | (16.4M) | (17.2M) | |
| End Period Cash Flow | 14.7M | 24.2M | 3.0M | 3.1M | 4.8M | 4.5M | |
| Change To Netincome | 799.4K | 4.0M | 248.1K | (296.0K) | (340.4K) | (323.4K) | |
| Depreciation | 15.4K | 3.6K | 380.0 | 9.5K | 28.7K | 30.1K | |
| Investments | 3.0M | 3.9M | (43.8M) | 14.3M | 13.0M | 13.6M | |
| Change Receivables | (15.4K) | 22.0K | 16.1K | (246.9K) | (222.2K) | (211.1K) | |
| Net Borrowings | (3.3M) | (1.4M) | (3.3M) | (2.3M) | (2.1M) | (2.0M) |
Lipocine Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lipocine or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lipocine's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lipocine stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.41 | |
β | Beta against NYSE Composite | 0.98 | |
σ | Overall volatility | 5.54 | |
Ir | Information ratio | 0.07 |
Lipocine Volatility Alert
Lipocine shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lipocine's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lipocine's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Lipocine Fundamentals Vs Peers
Comparing Lipocine's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lipocine's direct or indirect competition across all of the common fundamentals between Lipocine and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lipocine or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lipocine's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lipocine by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lipocine to competition |
| Fundamentals | Lipocine | Peer Average |
| Return On Equity | -0.58 | -0.31 |
| Return On Asset | -0.37 | -0.14 |
| Operating Margin | (12.00) % | (5.51) % |
| Current Valuation | 5.34 M | 16.62 B |
| Shares Outstanding | 5.32 M | 571.82 M |
| Shares Owned By Insiders | 3.03 % | 10.09 % |
| Shares Owned By Institutions | 9.16 % | 39.21 % |
| Number Of Shares Shorted | 108.89 K | 4.71 M |
| Price To Earning | 15.80 X | 28.72 X |
| Price To Book | 1.47 X | 9.51 X |
| Price To Sales | 2.36 X | 11.42 X |
| Revenue | 109.99 K | 9.43 B |
| Gross Profit | 500 K | 27.38 B |
| EBITDA | (14.94 M) | 3.9 B |
| Net Income | (16.35 M) | 570.98 M |
| Cash And Equivalents | 37.4 M | 2.7 B |
| Cash Per Share | 0.42 X | 5.01 X |
| Total Debt | 17.17 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 22.23 X | 2.16 X |
| Book Value Per Share | 3.83 X | 1.93 K |
| Cash Flow From Operations | (11.87 M) | 971.22 M |
| Short Ratio | 3.59 X | 4.00 X |
| Earnings Per Share | (3.14) X | 3.12 X |
| Target Price | 33.0 | |
| Number Of Employees | 17 | 18.84 K |
| Beta | 1.09 | -0.15 |
| Market Capitalization | 26.95 M | 19.03 B |
| Total Asset | 23 M | 29.47 B |
| Retained Earnings | (199.78 M) | 9.33 B |
| Working Capital | 20.23 M | 1.48 B |
| Current Asset | 29.41 M | 9.34 B |
| Current Liabilities | 1.57 M | 7.9 B |
Note: Acquisition by Krista Fogarty of 991 shares of Lipocine subject to Rule 16b-3 [view details]
Lipocine Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lipocine . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Lipocine Buy or Sell Advice
When is the right time to buy or sell Lipocine? Buying financial instruments such as Lipocine Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 1M | 1.1M | 1.2M | 1.5M | Total Assets | 52.5M | 37.5M | 23.0M | 29.7M |
Use Investing Ideas to Build Portfolios
In addition to having Lipocine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Discretionary ETFs Thematic Idea Now
Consumer Discretionary ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Lipocine Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.